Cyclo(-Arg-Ala-Asp-D-Phe-Glu) Trifluoroacetate

Cyclo(-Arg-Ala-Asp-D-Phe-Glu) Trifluoroacetate is a synthetic cyclic pentapeptide that has garnered significant interest in biochemical and pharmaceutical research due to its unique structural characteristics and versatile bioactivity profile. The cyclization of the peptide backbone imparts enhanced conformational stability and resistance to enzymatic degradation, making it a valuable tool for probing protein interactions and biological pathways. The presence of both D- and L-amino acids in its sequence further contributes to its resistance against proteolytic cleavage, thereby extending its functional lifespan in various experimental settings. Its sequence features a combination of charged, polar, and aromatic residues, which enables it to engage in a diverse array of molecular interactions. As a result, Cyclo(-Arg-Ala-Asp-D-Phe-Glu) Trifluoroacetate has found utility in multiple research domains, where it serves as a model compound for studying receptor-ligand binding, cell adhesion, and signal transduction mechanisms.

Peptide ligand-receptor interaction studies: Cyclo(-Arg-Ala-Asp-D-Phe-Glu) Trifluoroacetate is widely utilized in the investigation of ligand-receptor interactions, particularly those involving integrin families. Its cyclic structure allows for high-affinity binding to specific cell surface receptors, facilitating the elucidation of molecular recognition mechanisms. Researchers employ this pentapeptide to map binding sites, determine binding affinities, and dissect the structural features required for selective receptor engagement. By acting as a probe or competitive inhibitor, it aids in distinguishing between different receptor subtypes and in characterizing the dynamic processes underlying cellular signaling events.

Cell adhesion and migration assays: In the context of cell biology, Cyclo(-Arg-Ala-Asp-D-Phe-Glu) Trifluoroacetate is an effective agent for modulating cell adhesion and migration. Its sequence, which mimics naturally occurring motifs involved in extracellular matrix recognition, enables it to interfere with integrin-mediated cell attachment to substrates. This property is exploited in in vitro assays to study the regulation of cell motility, the role of adhesion molecules in tissue remodeling, and the mechanisms driving metastatic behavior in cancer research. By selectively blocking or enhancing cell-substrate interactions, it provides insights into the fundamental processes of cellular movement and tissue organization.

Drug delivery system development: The cyclic pentapeptide serves as a functional moiety in the design of targeted drug delivery systems. Its ability to recognize and bind specific cell surface receptors makes it an attractive candidate for conjugation with therapeutic agents or nanocarriers. By decorating delivery vehicles with Cyclo(-Arg-Ala-Asp-D-Phe-Glu) Trifluoroacetate, researchers can achieve receptor-mediated targeting, thereby improving the selectivity and efficiency of drug transport to desired cell populations. This strategy is particularly valuable in the development of advanced delivery platforms for molecular therapeutics, where precise targeting is essential for maximizing efficacy and minimizing off-target effects.

Biomaterials engineering: In materials science, the pentapeptide is incorporated into biomaterial surfaces to modulate cell-material interactions. Its presence on hydrogels, scaffolds, or coatings can enhance biocompatibility and promote specific cellular responses, such as adhesion, proliferation, or differentiation. By tailoring the presentation of Cyclo(-Arg-Ala-Asp-D-Phe-Glu) Trifluoroacetate on biomaterial interfaces, researchers can engineer microenvironments that direct cell fate and tissue integration. This application is instrumental in the advancement of tissue engineering and regenerative medicine, where the control of cell behavior at the material interface is crucial for successful outcomes.

Molecular imaging and diagnostic research: The unique binding properties of this cyclic peptide are harnessed in the development of molecular imaging probes and diagnostic agents. When labeled with suitable imaging reporters, it can target and visualize specific cell populations or tissue structures in vitro and in preclinical models. Its selectivity for certain receptors enables the detection of pathological changes associated with disease progression, providing valuable information for basic research and the validation of new diagnostic approaches. By integrating Cyclo(-Arg-Ala-Asp-D-Phe-Glu) Trifluoroacetate into imaging platforms, researchers gain powerful tools for non-invasive monitoring of biological processes and for the assessment of therapeutic interventions.

1. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

2. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

4. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry